Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matejka Rebolj

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Plos One|March 28, 2013
Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assaySarah Preisler, Matejka Rebolj, Anette Untermann, et al.
Acta Cytologica|March 25, 2011
Effects of streamlining cervical cancer screening the Dutch way: consequences of changes in the Dutch KOPAC-based follow-up protocol and consensus-based limitation of equivocal cytologyMartijn C Briët, Thomas H D Berger, Marjolein van Ballegooijen, et al.
Vaccine|January 15, 2013
Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in DenmarkBryan Goldman, Matejka Rebolj, Carsten Rygaard, et al.
International Journal of Cancer|November 29, 2025
Indicators to identify cancer screening providers with suboptimal case detection: A scoping reviewJiayao Lei, Milena Falcaro, Adam R Brentnall, et al.
International Journal of Cancer|September 4, 2008
No increased risk for cervical cancer after a broader definition of a negative Pap smearMatejka Rebolj, Marjolein van Ballegooijen, Folkert van Kemenade, et al.
BMJ (Clinical Research Ed.)|November 3, 2012
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort studyMatejka Rebolj, Theo Helmerhorst, Dik Habbema, et al.
British Journal of Cancer|October 9, 2015
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in DenmarkMatejka Rebolj, Johanne Rask, Marjolein van Ballegooijen, et al.
Journal of Medical Screening|February 4, 2014
Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studiesJanni Uyen Hoa Lam, Matejka Rebolj, Pierre-Antoine Dugué, et al.
BMJ (Clinical Research Ed.)|April 28, 2009
Incidence of cervical cancer after several negative smear results by age 50: prospective observational studyMatejka Rebolj, Marjolein van Ballegooijen, Elsebeth Lynge, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 22, 2014
Cervical cancer screening at crossroadsElsebeth Lynge, Carsten Rygaard, Miguel Vazquez-Prada Baillet, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Plos One|March 28, 2013
Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assaySarah Preisler, Matejka Rebolj, Anette Untermann, et al.
Acta Cytologica|March 25, 2011
Effects of streamlining cervical cancer screening the Dutch way: consequences of changes in the Dutch KOPAC-based follow-up protocol and consensus-based limitation of equivocal cytologyMartijn C Briët, Thomas H D Berger, Marjolein van Ballegooijen, et al.
Vaccine|January 15, 2013
Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in DenmarkBryan Goldman, Matejka Rebolj, Carsten Rygaard, et al.
International Journal of Cancer|November 29, 2025
Indicators to identify cancer screening providers with suboptimal case detection: A scoping reviewJiayao Lei, Milena Falcaro, Adam R Brentnall, et al.
International Journal of Cancer|September 4, 2008
No increased risk for cervical cancer after a broader definition of a negative Pap smearMatejka Rebolj, Marjolein van Ballegooijen, Folkert van Kemenade, et al.
BMJ (Clinical Research Ed.)|November 3, 2012
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort studyMatejka Rebolj, Theo Helmerhorst, Dik Habbema, et al.
British Journal of Cancer|October 9, 2015
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in DenmarkMatejka Rebolj, Johanne Rask, Marjolein van Ballegooijen, et al.
Journal of Medical Screening|February 4, 2014
Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studiesJanni Uyen Hoa Lam, Matejka Rebolj, Pierre-Antoine Dugué, et al.
BMJ (Clinical Research Ed.)|April 28, 2009
Incidence of cervical cancer after several negative smear results by age 50: prospective observational studyMatejka Rebolj, Marjolein van Ballegooijen, Elsebeth Lynge, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 22, 2014
Cervical cancer screening at crossroadsElsebeth Lynge, Carsten Rygaard, Miguel Vazquez-Prada Baillet, et al.
Pageof 9